Publication | Closed Access
Early clinical efficacy of TAS-120, a covalently bound FGFR inhibitor, in patients with cholangiocarcinoma
20
Citations
0
References
2017
Year
Surgical OncologyMedicineHepatobiliary TumorBiliary CancerClinical EfficacyPathologyCancer TreatmentFgfr InhibitorOncologyRadiation OncologyCancer Research
No additional data available for this publication yet. Check back later!